Financial Life Planners Grows Stake in Axon Enterprise, Inc (NASDAQ:AXON)

Financial Life Planners lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 41.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,146 shares of the biotechnology company's stock after acquiring an additional 338 shares during the period. Axon Enterprise accounts for approximately 0.6% of Financial Life Planners' holdings, making the stock its 22nd biggest holding. Financial Life Planners' holdings in Axon Enterprise were worth $603,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in AXON. Capital World Investors raised its position in Axon Enterprise by 86.4% in the 4th quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock worth $1,079,145,000 after purchasing an additional 841,772 shares during the period. Alliancebernstein L.P. raised its position in Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock worth $659,128,000 after purchasing an additional 812,337 shares during the period. Norges Bank purchased a new stake in Axon Enterprise in the 4th quarter worth about $482,081,000. GQG Partners LLC purchased a new stake in Axon Enterprise in the 4th quarter worth about $478,349,000. Finally, GAMMA Investing LLC raised its position in Axon Enterprise by 58,725.5% in the 1st quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock worth $402,210,000 after purchasing an additional 763,431 shares during the period. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Trading Up 1.8%

Shares of NASDAQ:AXON traded up $14.65 during trading on Friday, reaching $818.60. 1,010,596 shares of the company were exchanged, compared to its average volume of 540,419. The firm has a market capitalization of $63.73 billion, a PE ratio of 197.73, a P/E/G ratio of 92.54 and a beta of 1.29. The business's fifty day simple moving average is $714.97 and its 200-day simple moving average is $630.55. Axon Enterprise, Inc has a 12-month low of $279.02 and a 12-month high of $820.83. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. Axon Enterprise's revenue was up 31.3% compared to the same quarter last year. During the same period last year, the company posted $1.15 earnings per share. On average, research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Jennifer H. Mak sold 75 shares of Axon Enterprise stock in a transaction on Friday, June 13th. The stock was sold at an average price of $771.81, for a total transaction of $57,885.75. Following the completion of the transaction, the chief accounting officer now directly owns 15,240 shares in the company, valued at $11,762,384.40. This represents a 0.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 44,642 shares of company stock valued at $30,500,428 over the last ninety days. 4.40% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of recent analyst reports. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. Bank of America increased their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Barclays increased their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Finally, The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $699.55.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.